KIDS - OrthoPediatrics Corp.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
49.00
-0.04 (-0.08%)
At close: 4:00PM EST
Stock chart is not supported by your current browser
Previous Close49.04
Open48.76
Bid31.00 x 800
Ask0.00 x 1200
Day's Range48.07 - 49.38
52 Week Range28.19 - 51.48
Volume86,529
Avg. Volume103,908
Market Cap819.407M
Beta (5Y Monthly)0.29
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
All
News
Press Releases
  • GlobeNewswire

    OrthoPediatrics Corp. to Report Fourth Quarter and Full Year 2019 Financial Results on March 4, 2020

    OrthoPediatrics Corp. (“OrthoPediatrics”) (KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced today that the Company is scheduled to release its fourth quarter and full year 2019 financial results on Wednesday, March 4, 2020, after the market closes. OrthoPediatrics will host a conference call on Thursday, March 5, 2020, at 8:00 a.m. ET to discuss the results. The dial-in numbers are (855) 289-4603 for domestic callers and (614) 999-9389 for international callers.

  • GlobeNewswire

    OrthoPediatrics Corp. Reports Preliminary Unaudited Revenue for Fourth Quarter and Record Setting Full Year 2019

    WARSAW, Ind., Jan. 13, 2020 -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today.

  • GlobeNewswire

    OrthoPediatrics Corp. Announces Divestiture of the Vilex Adult Business

    OrthoPediatrics Corp. (“OrthoPediatrics”) (KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that it has completed the sale of substantially all of the assets related to the adult product offering of Vilex in Tennessee, Inc. (“Vilex Adult Business”) to Vilex LLC (“Buyer”), an affiliate of Squadron Capital LLC (“Squadron Capital”). In addition, Buyer was granted a license to manufacture and sell products utilizing the external fixation technology developed by Orthex, LLC, an affiliate of OrthoPediatrics, subject to certain restrictions in favor of OrthoPediatrics on sales to certain pediatric accounts.

  • GlobeNewswire

    OrthoPediatrics Corp. Announces U.S. Launch of QuickPack™

    OrthoPediatrics Corp. (“OrthoPediatrics”) (KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, is pleased to announce the U.S. launch of QuickPack™, a fully synthetic bone graft substitute featuring a high viscosity, calcium phosphate cement that closely mimics the mineral phase of natural bone. With mechanical properties close to those of cancellous bone, QuickPack produces a calcium-deficient apatite that has similar composition and structure to natural bone mineral.

  • GlobeNewswire

    OrthoPediatrics Corp. Announces Closing of Common Stock Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

    OrthoPediatrics Corp. (“OrthoPediatrics”) (KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced today the closing of its underwritten follow-on public offering of 1,805,500 shares of its common stock at a price to the public of $36.50 per share, which included the exercise in full by the underwriters of their option to purchase additional shares of common stock on the same terms and conditions. 1,755,500 of the shares were offered by OrthoPediatrics and 50,000 shares were offered by certain selling stockholders. Gross proceeds to OrthoPediatrics were approximately $64.1 million, before deducting underwriting discounts and commissions and offering expenses payable by OrthoPediatrics.

  • GlobeNewswire

    OrthoPediatrics Corp. Announces Pricing of Offering of Common Stock

    OrthoPediatrics Corp. (“OrthoPediatrics”) (KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, announced today the pricing of its underwritten public offering of 1,570,000 shares of its common stock at a price to the public of $36.50 per share. 1,520,000 of the shares are being offered by OrthoPediatrics and 50,000 shares are being offered by certain selling stockholders. OrthoPediatrics will not receive any proceeds from the sale of the shares by the selling stockholders.

  • GlobeNewswire

    OrthoPediatrics Corp. Announces Proposed Public Offering of Common Stock

    OrthoPediatrics Corp. (“OrthoPediatrics”) (KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, announced today that it is commencing an underwritten public offering of its common stock. OrthoPediatrics and certain of its stockholders are proposing to sell shares of common stock, including shares to be offered by certain selling stockholders. OrthoPediatrics will not receive any proceeds from the sale of the shares by the selling stockholders.

  • GlobeNewswire

    OrthoPediatrics Corp. to Sponsor the Annual International Pediatric Orthopaedic Symposium (IPOS)

    The Company will sponsor a pre-course meeting in addition to five spotlight sessions on a variety of topics WARSAW, Ind., Nov. 20, 2019 -- OrthoPediatrics Corp..

  • GlobeNewswire

    OrthoPediatrics Corp. Announces U.S. Launch of PediFoot Deformity Correction System

    OrthoPediatrics Corp. (“OrthoPediatrics”) (KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, is pleased to announce the domestic launch of the PediFoot Deformity Correction System (“PediFoot”), following 510(k) clearance by the U.S. Food and Drug Administration (FDA) in August. The PediFoot system is the first pediatric-specific system to treat deformities of the foot. Within the OrthoPediatrics product portfolio, this system offers the smallest plates and screws, which enable greater effectiveness in addressing cavus foot, flatfoot, clubfoot, and hallux valgus foot deformities.

  • GlobeNewswire

    OrthoPediatrics Corp. to Present at Two Upcoming Investor Conferences

    WARSAW, Ind., Nov. 11, 2019 -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ:KIDS), an orthopedic company focused exclusively on advancing the field of pediatric.

  • GlobeNewswire

    OrthoPediatrics Corp. Reports Third Quarter 2019 Financial Results

    Record quarterly revenue of $20.7 million, up 31.1% year-over-year WARSAW, Ind., Nov. 07, 2019 -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ:KIDS), a company focused.

  • GlobeNewswire

    OrthoPediatrics Corp. to Report Third Quarter 2019 Financial Results on November 7, 2019

    OrthoPediatrics Corp. (“OrthoPediatrics”) (KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced today that the Company is scheduled to release its third quarter 2019 financial results on Thursday, November 7, 2019, after the market closes. OrthoPediatrics will host a conference call on Friday, November 8, 2019, at 8:00 a.m. ET to discuss the results. The dial-in numbers are (855) 289-4603 for domestic callers and (614) 999-9389 for international callers.

  • GlobeNewswire

    OrthoPediatrics Corp. to Participate at the Cantor Fitzgerald Global Healthcare Conference

    WARSAW, Ind., Sept. 25, 2019 -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ:KIDS), an orthopedic company focused exclusively on advancing the field of pediatric.

  • GlobeNewswire

    OrthoPediatrics Corp. to Sponsor Three Medical Meetings in September 2019

    WARSAW, Ind., Sept. 16, 2019 -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics,.

  • GlobeNewswire

    OrthoPediatrics Corp. Announces U.S. Launch of Next Generation Cannulated Screw Systems

    OrthoPediatrics Corp. (“OrthoPediatrics”) (KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, is pleased to announce the U.S. launch of the next generation Cannulated Screw Systems for treating pediatric patients with fractures and fusions, following 510(k) clearance by the U.S. Food and Drug Administration in July. The new, innovative systems include expanded screw sizes that provide pediatric orthopedic surgeons additional intra-operative convenience. The systems were designed specifically for children by pediatric orthopedic surgeons with a high level of focus on extraction instrumentation.

  • GlobeNewswire

    OrthoPediatrics Corp. Receives FDA 510(k) Clearance for First Pediatric-Specific Foot System

    WARSAW, Ind., Aug. 19, 2019 -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics,.

  • GlobeNewswire

    OrthoPediatrics Corp. Reports Second Quarter 2019 Financial Results

    WARSAW, Ind., Aug. 07, 2019 -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ:KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced.

  • GlobeNewswire

    OrthoPediatrics Corp. to Participate in 4th Annual Needham Med Tech & Diagnostics Conference

    OrthoPediatrics Corp. (“OrthoPediatrics”) (KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced today that Mark Throdahl, President & Chief Executive Officer, and Fred Hite, Chief Financial Officer, are scheduled to attend the 4th Annual Needham Healthcare Conference on Tuesday, August 13, 2019, in New York. This conference will allow institutional investors to meet with the Company but does not include a formal presentation.

  • GlobeNewswire

    OrthoPediatrics Corp. to Report Second Quarter 2019 Financial Results on August 7, 2019

    OrthoPediatrics Corp. (“OrthoPediatrics”) (KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced today that the Company is scheduled to release its second quarter 2019 financial results on Wednesday, August 7, 2019, after the market closes. OrthoPediatrics will host a conference call on Thursday, August 8, 2019, at 8:00 a.m. ET to discuss the results. The dial-in numbers are (855) 289-4603 for domestic callers and (614) 999-9389 for international callers.

  • GlobeNewswire

    OrthoPediatrics Corp. Receives FDA 510(k) Clearance for Next Generation Cannulated Screw System

    WARSAW, Ind., July 23, 2019 -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics,.

  • GlobeNewswire

    OrthoPediatrics Corp. to Sponsor 26th Annual International Meeting on Advanced Spine Techniques (IMAST)

    OrthoPediatrics Corp. (“OrthoPediatrics”) (KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced today it will continue its support as a Gold Level sponsor for the 26th Annual International Meeting on Advanced Spine Techniques (IMAST). OrthoPediatrics is also a Gold Level sponsor for the Scoliosis Research Society (SRS), the parent organization of IMAST. More than 800 attendees, comprised mainly of orthopedic surgeons and neurosurgeons, are expected to attend this year’s event, which will take place July 17-20, 2019 in Amsterdam, the Netherlands.

  • GlobeNewswire

    OrthoPediatrics Corp. to Present at the JMP Life Sciences Conference

    WARSAW, Ind., June 10, 2019 -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ:KIDS), an orthopedic company focused exclusively on advancing the field of pediatric.

  • GlobeNewswire

    OrthoPediatrics Announces Acquisition of Vilex and Novel External Fixation Technology

    Vilex is primarily a foot and ankle surgery company with a product portfolio targeting pediatric patients and adults that generated $11.8 million in total sales, which are derived primarily from the U.S., and approximately $2.9 million of net income in full year 2018.

  • GlobeNewswire

    OrthoPediatrics Corp. to Continue Sponsorship for 2019 POSNA Meeting

    OrthoPediatrics Corp. (“OrthoPediatrics”) (KIDS), an orthopedic company focused exclusively on advancing the field of pediatric orthopedics, today announced the Company’s continued sponsorship for the 2019 Pediatric Orthopaedic Society of North America (POSNA) annual meeting, being held May 15-18 in Charlotte, NC. The Company will also highlight its Trauma, Deformity Correction, and Scoliosis product offerings at booths 37 and 38. More than 900 attendees from across the world are expected to participate in this year’s event, which will take place at the Charlotte Convention Center.

  • GlobeNewswire

    OrthoPediatrics Corp. Reports First Quarter 2019 Financial Results

    WARSAW, Ind., May 08, 2019 -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS), an orthopedic company focused exclusively on advancing the field of pediatric.